Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1164508 BOSTON, MA
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,087,087
+$5,665,482 QoQ
Shares Held
489,102
+376.5% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 238 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. RDY ranks #14 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,137,442 $225,456,582
2 VTRS
Viatris Inc
 8,371,218 $132,934,941
3 HLN
Haleon plc
 14,181,817 $132,316,352
4 INDV
Indivior Pharmaceuticals, Inc.
 1,642,086 $67,374,788
5 KNSA
Kiniksa Pharmaceuticals International, plc
 957,514 $61,233,020
6 TAK
Takeda Pharmaceutical Co Ltd
 3,732,924 $59,838,771
7 ANIP
Ani Pharmaceuticals Inc
 562,016 $46,523,684
8 ELAN
Elanco Animal Health Inc
 1,872,157 $46,073,783

All Filings in RDY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,087,087 489,102
2026-03-31 $1,421,605 102,643
2025-03-31 $5,203,520 394,505
2024-06-30 $3,546,796 46,552
2024-03-31 $7,698,155 104,951
2023-12-31 $2,023,525 29,082
2023-09-30 $16,653,706 249,046
2023-06-30 $9,290,296 147,208
2022-12-31 $455,658 8,805
2022-09-30 $536,589 10,252
2020-09-30 $4,331,849 62,275
2020-06-30 $10,567,914 199,357